Hep-C Drug Could Strain Insurance Companies
Apr 01, 2014 PM EDT
Sovaldi, a promising "breakthrough treatment" that can potentially cure a patient of hepatitis C, has been estimated to cost approximately $1000 a pill, potentially placing a heavy burden on an unprepared insurance providers, including the still-very..